Jørgen Bardenfleth

Deputy chairman, member of the Board of Directors since 2018

Education: MSc in Engineering from the Technical University of Denmark (DTU) and a MBA from the University of California, Los Angeles

Background: Professional board member since 2013, prior General Manager in high tech companies Microsoft, Intel and Hewlett-Packard 1989-2013. Board and steering committee work in Danish Science Parks, Innovationsfonden and Innovation Technology consortias.

Other ongoing assignments: Chairman of the Board in Lyngsoe Systems, Dubex, Symbion, Medical Technology Innovation Consortium (MTIC), COBIS and Impero. Board member in Bizbrains, Minerva, Accelerace, BLOXHUB (vice chair), CataCap et al.

Independence: Independent in relation to both the Company and executive management as well as larger shareholders

Scandion Oncology shares and warrants
425,629 shares and 53,585 warrants (partly owned via Lioneagle ApS)